Letter to the Editor-Recent advances in Lynch syndrome

Pål Møller; Julian Sampson; Mev Dominguez-Valentin; John Burn; Lone Sunde; Gabriela Möslein; Jukka Pekka Mecklin; Toni Seppälä

doi:10.1007/s10689-020-00200-6

Letter to the Editor-Recent advances in Lynch syndrome

Pål Møller^*
, Julian Sampson
, Mev Dominguez-Valentin
, John Burn
, Lone Sunde
, Gabriela Möslein
, Jukka Pekka Mecklin
, Toni Seppälä

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Scientific

Original language	English
Pages (from-to)	117-118
Number of pages	2
Journal	Familial Cancer
Volume	20
Issue number	2
DOIs	https://doi.org/10.1007/s10689-020-00200-6
Publication status	Published - Apr 2021
Externally published	Yes
Publication type	B1 Journal article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Genetics
Oncology
Genetics(clinical)
Cancer Research

Access to Document

10.1007/s10689-020-00200-6

Cite this

@article{0a954f4965ff41faabc5cf6052ede40c,

title = "Letter to the Editor-Recent advances in Lynch syndrome",

author = "P{\aa}l M{\o}ller and Julian Sampson and Mev Dominguez-Valentin and John Burn and Lone Sunde and Gabriela M{\"o}slein and Mecklin, \{Jukka Pekka\} and Toni Sepp{\"a}l{\"a}",

year = "2021",

month = apr,

doi = "10.1007/s10689-020-00200-6",

language = "English",

volume = "20",

pages = "117--118",

journal = "Familial Cancer",

issn = "1389-9600",

publisher = "Springer Science and Business Media B.V.",

number = "2",

}

TY - JOUR

T1 - Letter to the Editor-Recent advances in Lynch syndrome

AU - Møller, Pål

AU - Sampson, Julian

AU - Dominguez-Valentin, Mev

AU - Burn, John

AU - Sunde, Lone

AU - Möslein, Gabriela

AU - Mecklin, Jukka Pekka

AU - Seppälä, Toni

PY - 2021/4

Y1 - 2021/4

U2 - 10.1007/s10689-020-00200-6

DO - 10.1007/s10689-020-00200-6

M3 - Letter

C2 - 32770425

AN - SCOPUS:85089107790

SN - 1389-9600

VL - 20

SP - 117

EP - 118

JO - Familial Cancer

JF - Familial Cancer

IS - 2

ER -